{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:53:15Z","timestamp":1790704395023,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T00:00:00Z","timestamp":1472169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T00:00:00Z","timestamp":1472169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The role of sphingosine 1-phosphate (S1P) in liver fibrosis or inflammation was not fully examined in human. Controversy exists which S1P receptors, S1P1 and S1P3 vs S1P2, would be importantly involved in its mechanism. To clarify these matters, 80 patients who received liver resection for hepatocellular carcinoma and 9 patients for metastatic liver tumor were enrolled. S1P metabolism was analyzed in background, non-tumorous liver tissue. mRNA levels of sphingosine kinase 1 (SK1) but not SK2 were increased in livers with fibrosis stages 3\u20134 compared to those with 0\u20132 and to normal liver. However, S1P was not increased in advanced fibrotic liver, where mRNA levels of S1P transporter spinster homolog 2 (SPNS2) but not S1P-degrading enzymes were enhanced. Furthermore, mRNA levels of S1P2 but not S1P1 or S1P3 were increased in advanced fibrotic liver. These increased mRNA levels of SK1, SPNS2 and S1P2 in fibrotic liver were correlated with \u03b1-smooth muscle actin mRNA levels in liver, and with serum ALT levels. In conclusion, S1P may be actively generated, transported to outside the cells, and bind to its specific receptor in human liver to play a role in fibrosis or inflammation. Altered S1P metabolism in fibrotic liver may be their therapeutic target.<\/jats:p>","DOI":"10.1038\/srep32119","type":"journal-article","created":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T09:30:23Z","timestamp":1472203823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human"],"prefix":"10.1038","volume":"6","author":[{"given":"Masaya","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baasanjav","family":"Uranbileg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kurano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Saigusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junken","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harufumi","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Kokudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,26]]},"reference":[{"key":"BFsrep32119_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bbalip.2012.06.008","volume":"1831","author":"Y Takuwa","year":"2013","unstructured":"Takuwa, Y., Ikeda, H., Okamoto, Y., Takuwa, N. & Yoshioka, K. Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases. Biochimica et biophysica acta 1831, 185\u2013192, doi: 10.1016\/j.bbalip.2012.06.008 (2013).","journal-title":"Biochimica et biophysica acta"},{"key":"BFsrep32119_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrm1103","volume":"4","author":"S Spiegel","year":"2003","unstructured":"Spiegel, S. & Milstien, S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nature reviews. Molecular cell biology 4, 397\u2013407, doi: 10.1038\/nrm1103 (2003).","journal-title":"Nature reviews. Molecular cell biology"},{"key":"BFsrep32119_CR3","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/jcb.20127","volume":"92","author":"T Sanchez","year":"2004","unstructured":"Sanchez, T. & Hla, T. Structural and functional characteristics of S1P receptors. Journal of cellular biochemistry 92, 913\u2013922, doi: 10.1002\/jcb.20127 (2004).","journal-title":"Journal of cellular biochemistry"},{"key":"BFsrep32119_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1126\/science.1167449","volume":"323","author":"A Kawahara","year":"2009","unstructured":"Kawahara, A. et al. The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science (New York, N.Y.) 323, 524\u2013527, doi: 10.1126\/science.1167449 (2009).","journal-title":"Science (New York, N.Y.)"},{"key":"BFsrep32119_CR5","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1074\/jbc.M110.171116","volume":"286","author":"Y Hisano","year":"2011","unstructured":"Hisano, Y., Kobayashi, N., Kawahara, A., Yamaguchi, A. & Nishi, T. The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720. The Journal of biological chemistry 286, 1758\u20131766, doi: 10.1074\/jbc.M110.171116 (2011).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep32119_CR6","doi-asserted-by":"publisher","first-page":"e38941","DOI":"10.1371\/journal.pone.0038941","volume":"7","author":"Y Hisano","year":"2012","unstructured":"Hisano, Y., Kobayashi, N., Yamaguchi, A. & Nishi, T. Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PloS one 7, e38941, doi: 10.1371\/journal.pone.0038941 (2012).","journal-title":"PloS one"},{"key":"BFsrep32119_CR7","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1172\/jci60746","volume":"122","author":"S Fukuhara","year":"2012","unstructured":"Fukuhara, S. et al. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. The Journal of clinical investigation 122, 1416\u20131426, doi: 10.1172\/jci60746 (2012).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep32119_CR8","doi-asserted-by":"publisher","first-page":"37118","DOI":"10.1074\/jbc.M502207200","volume":"280","author":"M Maceyka","year":"2005","unstructured":"Maceyka, M. et al. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. The Journal of biological chemistry 280, 37118\u201337129, doi: 10.1074\/jbc.M502207200 (2005).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep32119_CR9","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","volume":"275","author":"SL Friedman","year":"2000","unstructured":"Friedman, S. L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 275, 2247\u20132250. (2000).","journal-title":"J Biol Chem."},{"key":"BFsrep32119_CR10","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman, S. L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655\u20131669, doi: 10.1053\/j.gastro.2008.03.003 (2008).","journal-title":"Gastroenterology"},{"key":"BFsrep32119_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/jci24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller, R. & Brenner, D. A. Liver fibrosis. The Journal of clinical investigation 115, 209\u2013218, doi: 10.1172\/jci24282 (2005).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep32119_CR12","doi-asserted-by":"publisher","first-page":"G304","DOI":"10.1152\/ajpgi.2000.279.2.G304","volume":"279","author":"H Ikeda","year":"2000","unstructured":"Ikeda, H. et al. Biological activities of novel lipid mediator sphingosine 1-phosphate in rat hepatic stellate cells. American journal of physiology. Gastrointestinal and liver physiology 279, G304\u2013G310 (2000).","journal-title":"American journal of physiology. Gastrointestinal and liver physiology"},{"key":"BFsrep32119_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1194\/jlr.M800496-JLR200","volume":"50","author":"H Ikeda","year":"2009","unstructured":"Ikeda, H. et al. Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2. Journal of lipid research 50, 556\u2013564, doi: 10.1194\/jlr.M800496-JLR200 (2009).","journal-title":"Journal of lipid research"},{"key":"BFsrep32119_CR14","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.bbrc.2004.04.207","volume":"320","author":"H Ikeda","year":"2004","unstructured":"Ikeda, H. et al. Sphingosine 1-phosphate enhances portal pressure in isolated perfused liver via S1P2 with Rho activation. Biochemical and biophysical research communications 320, 754\u2013759, doi: 10.1016\/j.bbrc.2004.04.207 (2004).","journal-title":"Biochemical and biophysical research communications"},{"key":"BFsrep32119_CR15","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/hep.25780","volume":"56","author":"Y Kageyama","year":"2012","unstructured":"Kageyama, Y. et al. Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents. Hepatology (Baltimore, Md.) 56, 1427\u20131438, doi: 10.1002\/hep.25780 (2012).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"BFsrep32119_CR16","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jhep.2009.01.028","volume":"50","author":"C Li","year":"2009","unstructured":"Li, C. et al. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. Journal of hepatology 50, 1174\u20131183, doi: 10.1016\/j.jhep.2009.01.028 (2009).","journal-title":"Journal of hepatology"},{"key":"BFsrep32119_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ajpath.2014.09.023","volume":"185","author":"L Xiu","year":"2015","unstructured":"Xiu, L. et al. Intracellular sphingosine 1-phosphate contributes to collagen expression of hepatic myofibroblasts in human liver fibrosis independent of its receptors. The American journal of pathology 185, 387\u2013398, doi: 10.1016\/j.ajpath.2014.09.023 (2015).","journal-title":"The American journal of pathology"},{"key":"BFsrep32119_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1124\/pr.107.07113","volume":"60","author":"K Takabe","year":"2008","unstructured":"Takabe, K., Paugh, S. W., Milstien, S. & Spiegel, S. \u201cInside-out\u201d signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacological reviews 60, 181\u2013195, doi: 10.1124\/pr.107.07113 (2008).","journal-title":"Pharmacological reviews"},{"key":"BFsrep32119_CR19","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1096\/fj.06-6889com","volume":"21","author":"V Serriere-Lanneau","year":"2007","unstructured":"Serriere-Lanneau, V. et al. The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 21, 2005\u20132013, doi: 10.1096\/fj.06-6889com (2007).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"BFsrep32119_CR20","doi-asserted-by":"publisher","first-page":"e41834","DOI":"10.1371\/journal.pone.0041834","volume":"7","author":"Q Liu","year":"2012","unstructured":"Liu, Q. et al. Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats. Plos one 7, e41834, doi: 10.1371\/journal.pone.0041834 (2012).","journal-title":"Plos one"},{"key":"BFsrep32119_CR21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jhep.2010.08.028","volume":"54","author":"C Li","year":"2011","unstructured":"Li, C. et al. Sphingosine 1-phosphate (S1P)\/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility. Journal of hepatology 54, 1205\u20131213, doi: 10.1016\/j.jhep.2010.08.028 (2011).","journal-title":"Journal of hepatology"},{"key":"BFsrep32119_CR22","doi-asserted-by":"publisher","first-page":"30684","DOI":"10.1074\/jbc.M115.671735","volume":"290","author":"R Wang","year":"2015","unstructured":"Wang, R. et al. Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration. The Journal of biological chemistry 290, 30684\u201330696, doi: 10.1074\/jbc.M115.671735 (2015).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep32119_CR23","doi-asserted-by":"publisher","first-page":"e1004688","DOI":"10.1371\/journal.pgen.1004688","volume":"10","author":"J Chen","year":"2014","unstructured":"Chen, J. et al. Spinster homolog 2 (spns2) deficiency causes early onset progressive hearing loss. Plos genetics 10, e1004688, doi: 10.1371\/journal.pgen.1004688 (2014).","journal-title":"Plos genetics"},{"key":"BFsrep32119_CR24","doi-asserted-by":"publisher","first-page":"10690","DOI":"10.1074\/jbc.M700370200","volume":"282","author":"M Kono","year":"2007","unstructured":"Kono, M. et al. Deafness and stria vascularis defects in S1P2 receptor-null mice. The Journal of biological chemistry 282, 10690\u201310696, doi: 10.1074\/jbc.M700370200 (2007).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep32119_CR25","doi-asserted-by":"publisher","first-page":"e0149462","DOI":"10.1371\/journal.pone.0149462","volume":"11","author":"B Uranbileg","year":"2016","unstructured":"Uranbileg, B. et al. Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence. Plos one 11, e0149462, doi: 10.1371\/journal.pone.0149462 (2016).","journal-title":"Plos one"},{"key":"BFsrep32119_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.cca.2010.02.063","volume":"411","author":"H Ikeda","year":"2010","unstructured":"Ikeda, H. et al. Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C. Clinica chimica acta; international journal of clinical chemistry 411, 765\u2013770, doi: 10.1016\/j.cca.2010.02.063 (2010).","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"BFsrep32119_CR27","doi-asserted-by":"publisher","first-page":"14196","DOI":"10.1073\/pnas.95.24.14196","volume":"95","author":"P Xia","year":"1998","unstructured":"Xia, P. et al. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proceedings of the National Academy of Sciences of the United States of America 95, 14196\u201314201 (1998).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep32119_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.tem.2007.07.005","volume":"18","author":"SE Alvarez","year":"2007","unstructured":"Alvarez, S. E., Milstien, S. & Spiegel, S. Autocrine and paracrine roles of sphingosine-1-phosphate. Trends in endocrinology and metabolism: TEM 18, 300\u2013307, doi: 10.1016\/j.tem.2007.07.005 (2007).","journal-title":"Trends in endocrinology and metabolism: TEM"},{"key":"BFsrep32119_CR29","doi-asserted-by":"publisher","first-page":"52487","DOI":"10.1074\/jbc.M406512200","volume":"279","author":"ML Allende","year":"2004","unstructured":"Allende, M. L. et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. The Journal of biological chemistry 279, 52487\u201352492, doi: 10.1074\/jbc.M406512200 (2004).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep32119_CR30","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.2353\/ajpath.2010.091257","volume":"177","author":"A Moles","year":"2010","unstructured":"Moles, A. et al. Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis. The American journal of pathology 177, 1214\u20131224, doi: 10.2353\/ajpath.2010.091257 (2010).","journal-title":"The American journal of pathology"},{"key":"BFsrep32119_CR31","doi-asserted-by":"crossref","unstructured":"Grammatikos, G. et al. Serum sphingolipidomic analyses reveal an upregulation of C16- ceramide and sphingosine-1-phosphate in hepatocellular carcinoma. Oncotarget, doi: 10.18632\/oncotarget.7741 (2016).","DOI":"10.18632\/oncotarget.7741"},{"key":"BFsrep32119_CR32","doi-asserted-by":"publisher","first-page":"e0138130","DOI":"10.1371\/journal.pone.0138130","volume":"10","author":"G Grammatikos","year":"2015","unstructured":"Grammatikos, G. et al. Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis. Plos one 10, e0138130, doi: 10.1371\/journal.pone.0138130 (2015).","journal-title":"Plos one"},{"key":"BFsrep32119_CR33","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/hep.27587","volume":"61","author":"G Grammatikos","year":"2015","unstructured":"Grammatikos, G. et al. Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection. Hepatology (Baltimore, Md.) 61, 812\u2013822, doi: 10.1002\/hep.27587 (2015).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"BFsrep32119_CR34","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.bbalip.2014.04.007","volume":"1841","author":"G Grammatikos","year":"2014","unstructured":"Grammatikos, G. et al. Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease. Biochimica et biophysica acta 1841, 1012\u20131020, doi: 10.1016\/j.bbalip.2014.04.007 (2014).","journal-title":"Biochimica et biophysica acta"},{"key":"BFsrep32119_CR35","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1194\/jlr.D048439","volume":"55","author":"M Okudaira","year":"2014","unstructured":"Okudaira, M. et al. Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl-2-lysophospholipids in biological samples by LC-MS\/MS. Journal of lipid research 55, 2178\u20132192, doi: 10.1194\/jlr.D048439 (2014).","journal-title":"Journal of lipid research"},{"key":"BFsrep32119_CR36","doi-asserted-by":"crossref","unstructured":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology (Baltimore, Md.) 20, 15\u201320 (1994).","DOI":"10.1002\/hep.1840200104"},{"key":"BFsrep32119_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa, P. & Poynard, T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology (Baltimore, Md.) 24, 289\u2013293, doi: 10.1002\/hep.510240201 (1996).","journal-title":"Hepatology (Baltimore, Md.)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep32119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32119","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T06:09:43Z","timestamp":1672898983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep32119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,26]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,8,31]]}},"alternative-id":["BFsrep32119"],"URL":"https:\/\/doi.org\/10.1038\/srep32119","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,26]]},"assertion":[{"value":"20 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32119"}}